Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Evolution of Heteroresistance

Obiettivo

Antibiotic resistance is a major threat to global health, associated with ≈ 5 million deaths annually. While the field has largely focused on the emergence of stable resistance through mutation or horizontal gene transfer, a critical evolutionary unstable intermediate remains underexplored: heteroresistance (HR). In HR, a rare subpopulation within a main susceptible bacterial population exhibits transient high-level resistance — a phenotype that enables survival and growth under antibiotic pressure and paves the way to stable resistance. HR is often caused by increased copy number of resistance genes with low expression or activity. While cells carrying a single gene copy are susceptible, those with elevated copy numbers become resistant, and can replicate under antibiotic exposure, potentially leading to treatment failure.
This project proposes a paradigm shift in our understanding of resistance evolution. Recent discoveries from our lab have revealed, across diverse bacterial pathogens, three novel and prevalent mechanisms by which HR emerges through increased gene copy number. These mechanisms generate subpopulations that evade antibiotic killing, yet revert rapidly in the absence of selection allowing the main population to remain fit. This duality makes HR an exceptionally flexible, but clinically dangerous, adaptive strategy. Despite its significance, the evolutionary origin(s) and consequences of HR remain unknown. This proposal seeks to fill that critical gap. We will (i) define the genetic and selective conditions that allow susceptible populations to evolve HR; (ii) determine how HR acts as a stepping stone toward stable resistance; and (iii) explore the potential of HR to promote horizontal gene transfer of resistance genes. By resolving these fundamental unknowns, this project will establish HR as a central driver in the evolution of antimicrobial resistance and inform future diagnostics and treatment strategies.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2025-ADG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

UPPSALA UNIVERSITET
Contributo netto dell'UE
€ 2 499 805,00
Indirizzo
VON KRAEMERS ALLE 4
751 05 Uppsala
Svezia
Regione
Östra Sverige Östra Mellansverige Uppsala län
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato

Beneficiari (1)